{"transactions":[{"id":744758,"issuer":{"id":3948,"kind":"organization","name":"Dyne Therapeutics, Inc.","symbol":"DYN"},"owners":[{"id":40091,"kind":"person","name":"Incerti Carlo","position":1,"cik":"0001915358","reported_name":"Incerti Carlo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-06-09T21:12:25.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":35152,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 5, 2026. The shares underlying the option are scheduled to vest in full on the earlier of (i) June 5, 2027 or (ii) the date of the Issuer's 2027 Annual Meeting of Stockholders, subject to continued service."}],"balance_after":35152,"derivative":{"exercise_price":17.04,"expiration_date":"2036-06-04","underlying":"Common Stock","underlying_shares":35152},"source":{"system":"sec-edgar","filing":"0001193125-26-264019","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818794/000119312526264019/ownership.xml","form_type":"4"}},{"id":1125254,"issuer":{"id":3948,"kind":"organization","name":"Dyne Therapeutics, Inc.","symbol":"DYN"},"owners":[{"id":40091,"kind":"person","name":"Incerti Carlo","position":1,"cik":"0001915358","reported_name":"Incerti Carlo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-06-04T01:38:05.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 30, 2025. The shares underlying the option are scheduled to vest in full on the earlier of (i) May 30, 2026 or (ii) the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to continued service."}],"balance_after":35000,"derivative":{"exercise_price":11.96,"expiration_date":"2035-05-29","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0000950170-25-081354","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818794/000095017025081354/ownership.xml","form_type":"4"}},{"id":1361906,"issuer":{"id":3948,"kind":"organization","name":"Dyne Therapeutics, Inc.","symbol":"DYN"},"owners":[{"id":40091,"kind":"person","name":"Incerti Carlo","position":1,"cik":"0001915358","reported_name":"Incerti Carlo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2024-11-19T00:42:09.000Z","date":"2024-11-18","kind":"exercise","planned":false,"acquired":false,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted on March 2, 2022. The shares underlying the option are scheduled to vest over three years in equal monthly installments through March 2, 2025."}],"balance_after":22693,"derivative":{"exercise_price":8.69,"expiration_date":"2032-03-01","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0000950170-24-128176","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818794/000095017024128176/ownership.xml","form_type":"4"}},{"id":1361905,"issuer":{"id":3948,"kind":"organization","name":"Dyne Therapeutics, Inc.","symbol":"DYN"},"owners":[{"id":40091,"kind":"person","name":"Incerti Carlo","position":1,"cik":"0001915358","reported_name":"Incerti Carlo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-19T00:42:09.000Z","date":"2024-11-18","kind":"sale","planned":false,"acquired":false,"shares":16500,"price":28.73,"value":474045.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $28.47 to $29.13, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote of this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-24-128176","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818794/000095017024128176/ownership.xml","form_type":"4"}},{"id":1361904,"issuer":{"id":3948,"kind":"organization","name":"Dyne Therapeutics, Inc.","symbol":"DYN"},"owners":[{"id":40091,"kind":"person","name":"Incerti Carlo","position":1,"cik":"0001915358","reported_name":"Incerti Carlo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-19T00:42:09.000Z","date":"2024-11-18","kind":"exercise","planned":false,"acquired":true,"shares":16500,"price":8.69,"value":143385.0,"ownership":{"direct":true},"balance_after":16500,"source":{"system":"sec-edgar","filing":"0000950170-24-128176","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818794/000095017024128176/ownership.xml","form_type":"4"}},{"id":1502168,"issuer":{"id":3948,"kind":"organization","name":"Dyne Therapeutics, Inc.","symbol":"DYN"},"owners":[{"id":40091,"kind":"person","name":"Incerti Carlo","position":1,"cik":"0001915358","reported_name":"Incerti Carlo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2024-05-24T21:10:25.000Z","date":"2024-05-22","kind":"grant","planned":false,"acquired":true,"shares":25133,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 22, 2024. The shares underlying the option are scheduled to vest in full on the earlier of (i) May 22, 2025 or (ii) the date of the Issuer's 2025 Annual Meeting of Stockholders, subject to continued service."}],"balance_after":25133,"derivative":{"exercise_price":31.53,"expiration_date":"2034-05-21","underlying":"Common Stock","underlying_shares":25133},"source":{"system":"sec-edgar","filing":"0000950170-24-064727","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818794/000095017024064727/ownership.xml","form_type":"4"}},{"id":1878264,"issuer":{"id":3948,"kind":"organization","name":"Dyne Therapeutics, Inc.","symbol":"DYN"},"owners":[{"id":40091,"kind":"person","name":"Incerti Carlo","position":1,"cik":"0001915358","reported_name":"Incerti Carlo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-25T22:37:04.000Z","date":"2023-05-24","kind":"grant","planned":false,"acquired":true,"shares":24900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 24, 2023. The shares underlying the option are scheduled to vest in full on the earlier of (i) May 24, 2024 or (ii) the date of the Issuer's 2024 Annual Meeting of Stockholders."}],"balance_after":24900,"derivative":{"exercise_price":13.49,"expiration_date":"2033-05-23","underlying":"Common Stock","underlying_shares":24900},"source":{"system":"sec-edgar","filing":"0001209191-23-032275","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818794/000120919123032275/doc4.xml","form_type":"4"}},{"id":2350625,"issuer":{"id":3948,"kind":"organization","name":"Dyne Therapeutics, Inc.","symbol":"DYN"},"owners":[{"id":40091,"kind":"person","name":"Incerti Carlo","position":1,"cik":"0001915358","reported_name":"Incerti Carlo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-03-04T23:23:21.000Z","date":"2022-03-02","kind":"grant","acquired":true,"shares":39193,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on March 2, 2022. The shares underlying the option are scheduled to vest over three years in equal monthly installments through March 2, 2025."}],"balance_after":39193,"derivative":{"exercise_price":8.69,"expiration_date":"2032-03-01","underlying":"Common Stock","underlying_shares":39193},"source":{"system":"sec-edgar","filing":"0001209191-22-016460","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818794/000120919122016460/doc4.xml","form_type":"4"}}]}